NEW YORK, March 13, 2017 -- The Nasdaq Stock Market announced today that it will delist the common stock Class A of Spanish Broadcasting System, Inc. Spanish Broadcasting System, Inc.’s stock was suspended on January 19, 2017 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock of Acura Pharmaceuticals, Inc. Acura Pharmaceuticals, Inc.’s stock was suspended on February 23, 2017 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock, Vanguard Natural Resources 7.875% Series A Cumulative Redeemable Perpetual Preferred Units, Vanguard Natural Resources LLC 7.625% Series B Cumulative Redeemable Perpetual Preferred Unit, and Vanguard Natural Resources LLC 7.75% Series C Cumulative Redeemable Perpetual Preferred Units of Vanguard Natural Resources LLC. Vanguard Natural Resources LLC’s shares were suspended on February 13, 2017 and have not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock of DS Healthcare Group, Inc. DS Healthcare Group, Inc.’s stock was suspended on December 23, 2016 and has not traded on Nasdaq since that time.
Finally, Nasdaq announced that it will delist the common stock of Towerstream Corporation. Towerstream Corporation’s stock was suspended on December 01, 2016 and has not traded on Nasdaq since that time.
Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting for each of these companies. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delistings and whether the companies’ securities are trading on another venue, please review the companies’ public filings or contact the company directly.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: http://www.cchwallstreet.com/NasdaqTools/bookmark.asp?id=nasdaq-rule_5800&manual=/nasdaq/main/nasdaq-equityrules/.
NDAQO


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 



